Characterization of G2L3 (GAS2-like 3), a new microtubule- and actin-binding protein related to spectraplakins by Stroud, Matthew J et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1074/jbc.M111.242263
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Stroud, M. J., Kammerer, R. A., & Ballestrem, C. (2011). Characterization of G2L3 (GAS2-like 3), a new
microtubule- and actin-binding protein related to spectraplakins. Journal of Biological Chemistry, 286(28), 24987-
95. 10.1074/jbc.M111.242263
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
Characterization of G2L3 (GAS2-like 3), a NewMicrotubule-
and Actin-binding Protein Related to Spectraplakins*□S
Received for publication,March 23, 2011, and in revised form, May 5, 2011 Published, JBC Papers in Press,May 11, 2011, DOI 10.1074/jbc.M111.242263
Matthew J. Stroud, Richard A. Kammerer1,2, and Christoph Ballestrem1,3
From the Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester,
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The microtubule (MT) and actin cytoskeletons are funda-
mental to cell integrity, because they control a host of cellular
activities, including cell division, growth, polarization, and
migration. Proteins involved in mediating the cross-talk
between MT and actin cytoskeletons are key to many cellular
processes and play important physiological roles. We identified
a new member of the GAS2 family of MT-actin cross-linking
proteins, namedG2L3 (GAS2-like 3).We show thatGAS2-like 3
is widely conserved throughout evolution and is ubiquitously
expressed in human tissues. GAS2-like 3 interacts with filamen-
tous actin and MTs via its single calponin homology type 3
domain and C terminus, respectively. Interestingly, the role of
the putative MT-binding GAS2-related domain is to modulate
the binding of GAS2-like 3 to both filamentous actin and MTs.
This is in contrast to GAS2-related domains found in related
proteins, where it functions as a MT-binding domain. Further-
more, we show that tubulin acetylation drivesGAS2-like 3 local-
ization toMTs andmay provide functional insights into the role
of GAS2-like 3.
The cytoskeleton is fundamental to cellular integrity, provid-
ing amolecular framework for bothmechanical support and an
intracellular transport infrastructure (1). Until recently, the
microtubule (MT)4 and actin cytoskeletons have been investi-
gated as separate entities; however, it has become clear that
they function in an interdependent way (2, 3). For example,
MTs use filamentous actin (F-actin) to guide them from the cell
interior to focal adhesions at the cell periphery (4). Understand-
ing how the two components interact will therefore be key to
our further understanding of fundamental cellular processes,
such as cell division, growth, polarization, and migration.
The spectraplakins are a well characterized example of a pro-
tein family that can cross-link MT and actin cytoskeletons (5).
There are two members expressed in mammals, microtubule-
actin cross-linking factor 1 (MACF1 or ACF7), and bullous
pemphigoid antigen 1, both of which are huge, multidomain-
containing proteins (500 kDa in mass) with binding sites for
both F-actin via their calponin homology (CH) domains and
MTs via their GAS2-related (GAR) domain and/or GSR
repeats. Ablation of theACF7 gene inmice results in embryonic
lethality. However, ACF7/ cells can be derived from the
embryo and display defects inMT dynamics, guidance, cortical
tethering, stability, and cellular polarization (3). Accordingly,
variousmedical conditions and developmental defects arise as a
result of mutations in genes encoding spectraplakins, including
mental retardation, cancer, and chronic skin blistering (6),
underlining the importance of proteins that link the actin and
MT cytoskeletons.
Whereas the role of spectraplakins in cross-linking the MT
and actin cytoskeletons iswell established (3, 4, 7), the functions
of the relatedGAS2 family remain to be determined. TheGAS2
family can be thought of as mini-versions of spectraplakins,
because they too contain a putative actin-binding CH domain
and a putative MT-binding GAR domain. Interestingly, the
expression of a mini-version of ACF7 consisting of the CH and
GAR domains is sufficient to rescue these perturbations in
function, implying that these are the key functional domains of
spectraplakins (3). The first identified member of the GAS2
cross-linking family, termed GAS2, was originally identified in
a screen looking for genes induced by growth arrest (8). GAS2
localizes along actin stress fibers, and GAS2 phosphorylation is
coupled to rearrangements of actin in G0 to G1 transition (9,
10). There is some evidence to suggest that it may also be
involved in apoptosis and tumor suppression (10–12). Two
related family members were identified either in a search for
putative tumor suppressors (hGAR22 (human Gas2-related
gene on chromosome 22) or G2L1 (GAS2-like 1)) or by
sequence similarity to hGAR22 (hGAR17 (humanGas2-related
gene on chromosome 17) or G2L2 (GAS2-like 2)) (2, 13). Both
transcripts encoding the respective proteins are subject to
alternative splicing, which results in proteins with different
localization and binding properties. The shorter isoforms,
termed hG2L1 and hG2L2, predominantly localize to the
actin cytoskeleton and interact with F-actin in vitro. Con-
versely, both of the longer isoforms, termed hG2L1 and
hG2L2, localize and bind to both F-actin and MTs (2), sug-
gesting that they may play a role in mediating cross-talk
between the cytoskeletal systems.
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In the present study, we describe the characterization of a
new family member, G2L3 (GAS2-like 3), which has the poten-
tial to communicate between MTs and actin. G2L3 is widely
conserved through evolution, and it is abundant inmost human
tissues and the majority of cell lines that we tested. Full-length
G2L3 interacts with both F-actin and MTs in cells and in vitro
via its CH domain and C terminus, respectively. A third
domain, termed the GAR domain, does not directly bind to
F-actin orMTs; however, it is involved in modulating the bind-
ing strength of G2L3 to each cytoskeletal system. Interestingly,
we found that acetylation of -tubulin contributes to the
recruitment of G2L3 to MTs.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfections—All cells were grown in
DMEM (Sigma-Aldrich) supplemented with 10% FBS and 1%
glutamine in a 5% CO2 in a humidified incubator and passaged
in a 1:10 dilution every 3 days. For transfections, the cells were
plated in six-well dishes a day before transfections. For tran-
sient transfections, 1–1.5 g of DNA in total was transfected
into cells using Lipofectamine Plus (Invitrogen) in accordance
with the manufacturer’s instructions. The cells were replated
after 3 h in glass-bottomed dishes (MatTek Corporation, Ash-
land, MA) coated with 10 g/ml bovine fibronectin (Sigma).
For drug treatments, the cells were incubated for 30 min with
either nocodazole (10 M), cytochalasin D (2 M), or trichosta-
tin A (TSA) (5 M) (all from Sigma).
Immunofluorescence Imaging—The cells were fixed and per-
meabilized with 3% paraformaldehyde (Sigma) containing
0.25% Triton X-100 (Sigma) and 0.05% glutaraldehyde (Sigma)
for 15 min, before being washed in PBS (Lonza, Verviers, Bel-
gium). Autofluorescence from reactive amine groups was
quenched using 0.01% sodium tetrahydroborate (Sigma) in PBS
for 15 min before being washed in PBS. Subsequently the cells
were incubated for 45 min with anti-tubulin or anti-acetylated
tubulin antibodies at 1:500 dilution (DM1A and 6-11B-1,
respectively; Sigma), followed by three washes with PBS. Sec-
ondary antibodies conjugated to Cy2, Cy3, or Cy5 (Jackson
ImmunoResearch Laboratories, Suffolk, UK) were then applied
for 30 min. In the case of colabeling for actin, Texas Red or
FITC-labeled phalloidin (Invitrogen) was added together with
the secondary antibody). The cells were then washed three
more times in PBS before being imaged using an oil-immersed
100 objective, with 1.35 numerical aperture on an inverted
microscope (IX71; Olympus) controlled by a Deltavision sys-
tem (Applied Precision, Issaquah, WA). Images were captured
using a Coolsnap HQ CCD camera (Princeton Instruments,
Lurgan, UK).
Fluorescence Recovery after Photobleaching (FRAP)—An
inverted microscope (IX70) equipped with a 488-nm laser line
(Olympus) under the control of software (DeltaVisionRT) were
used for FRAP experiments. Cells plated on glass-bottomed
dishes and expressing the indicated GFP-tagged constructs
were imaged at 37 °C in Ham’s F-12 medium (Sigma). 1.5-m-
diameter regions of interest were selected. Half-times of recov-
ery were calculated using softWoRx FRAP analysis suite (see
application notes at theApplied Precisionwebsite). Upon point
bleaching, there is a natural occurrence of bleaching outside the
region of interest. This is automatically adjusted for by the soft-
WoRx suite (Applied Precision), which normalizes the fluores-
cence intensity readings to adjacent background levels and
enables accurate readings to be measured. For image display,
we have now adjusted the brightness of the individual time
points accordingly. When performing FRAP on G2L3-express-
ing cells, we selected subcellular areas where G2L3 localized to
either actin filaments (see Fig. 4A) or MTs (see Fig. 4B).
Image Processing—The images were processed using ImageJ
version 1.43R. To quantify subcellular G2L3 localization, cells
were selected at random, and G2L3 localization was scored as
either diffuse, to actin alone, toMTs alone, or to bothMTs and
actin (see Fig. 5B). For colocalization studies and calculation of
the ratio of GAS2-like 3/MTs for TSA analysis, images were
background-subtracted using a two-dimensional bandpass fil-
ter, and overlay images were created. From these, a threshold
was set to restrict analyses to MTs, and the outline of the cell
was drawn followed by measuring the percentage area of posi-
tive pixels. This was repeated for GAS2-like 3 and divided by
the value given for MTs to give a ratio theoretically between 0
and 1 (see Fig. 6C). Adobe Photoshop CS4 was used in the
preparation of figures for this manuscript.
cDNA Panels—To identify human tissue expression, a “mas-
ter mix” containing forward and reverse primers, dNTPs, reac-
tion buffer, and Taq polymerase was made for cDNA panels
(Clontech). cDNA libraries from various cell lines were made
using the Absolutely RNA microprep kit followed by the Stra-
tascript QPCR cDNA synthesis kit (Stratagene, Cheshire, UK)
according to the manufacturer’s recommendations. A master
mix was also made to identify expression in the cell lines HeLa,
human foreskin fibroblasts, HT1080, HEK293T, and murine
NIH3T3.The total reaction volume for each reactionwas 25l;
the reactions were incubated at 94 °C for 1 min, followed by 35
cycles of 30 s at 94 °C (denaturation), 30 s at 55 °C (annealing),
and 60 s at 72 °C (extension). The reaction products were sub-
sequently run on a 1% agarose (w/v) gel for 1 h at 120 V.
Subcloning—For immunofluorescence, the CH domain,
C-term, GAR, and CH constructs were cloned into
pEGFP-N1 or mCherry-N1 vectors (Clontech) using the
restriction endonucleases NheI and HindIII at the sites indi-
cated in Fig. 1A. The other constructs were all cloned into the
pEGFP-C1 vector (Clontech) using the restriction endonu-
cleases BspEI and BamHI for GAS2-like 3, EcoRI and BamHI
for the GAR domain, and BamHI for the C terminus.
For recombinant expression in Escherichia coli, the CH
domain and C terminus were cloned into the pHisTrx2 vector
(14) using the restriction endonucleases BamHI and EcoRI
or BamHI, respectively. The GAR domain was cloned into
pHisNusA, a derivative of pET-43 (Invitrogen), using the same
restriction sites as for immunofluorescence. All of the recom-
binant insert DNA was verified by DNA sequencing.
Protein Expression and Purification—The recombinant
GAS2-like 3 constructs were expressed in E. coli JM109 (DE3)
host strain (Merck) as previously described (15) using an auto-
induction protocol (as described in Ref. 16). The His6-tagged
proteins were purified by immobilized metal affinity chroma-
tography onNi2-Sepharose (GEHealthcare). Purification was
performed as described in the pET system manual (Merck).
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FIGURE1.Schematic representationof the intron-exonboundariesof theG2L3geneand the sequencealignmentsof thehumanGAS2protein family.
A, the G2L3 gene consists of eight exons interspersed by seven introns. The CH and GAR domains are depicted in red and yellow, respectively, and the C
terminus (C-term) is in green. B, sequence alignment of the GAS2 family, showing the conservation between the N termini of the GAS2 family members. The
-isoforms of G2L1 and G2L2 are shown. Note the high degree of conservation between family members. The colored bars above the alignments indicate the
domain boundaries of the GAS2 family and are colored according to their domains as in A. AAs are illustrated according to their physicochemical properties
using the Zappo color scheme. In brief, aliphatic or hydrophobic AAs are pink, aromatic AAs are orange, positively chargedAAs are red, negatively chargedAAs
are green, hydrophilic AAs are blue, proline/glycine ismagenta, and cysteine is yellow.C, the AApercentage identities betweenG2L3 and the other GAS2 family
members are indicated, as well as the percentage identities between the various domains.
G2L3, a NewMT- and Actin-binding Protein
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Removal of the His6 tags by thrombin from the CH domain and
C terminus was performed as previously described (15). Deter-
mination of protein concentration was achieved by the absor-
bance of tryptophan and tyrosine residues at 280 nm (17).
In Vitro Sedimentation Assays—Actin and MT binding
assays were performed using the Non-Muscle Actin Binding
Protein Spin-Down Biochem kit and the Microtubule Associ-
ated Protein Spin-Down assay kit (both from Cytsokeleton,
Inc.), respectively, according to themanufacturer’s recommen-
dations. Briefly, the proteins were prespun at 150,000  g at
4 °C for 90 min for the actin binding assay or at 100,000 g at
25 °C for 1 h for the MT binding assay. The proteins were then
incubated with the polymerized forms of either F-actin orMTs
and centrifuged at 150,000  g at 24 °C for 90 min or at
100,000 g at 25 °C for 40 min, respectively. The supernatants
were aspirated and boiled in SDS sample buffer, and the pellets
were resuspended in SDS sample buffer. Following which, the
samples were analyzed on 10% SDS-PAGE gels for the GAR
domain andC terminus, and 15% SDS-PAGE gels were used for
the CH domain. All of the protein bands were visualized using
Coomassie Blue staining.
Sequence Alignments—Sequence alignments were performed
using the program Jalview (18).
Statistical Analysis—Using the ratios obtained from the
image processing, Student’s t tests were performed using
Microsoft Excel to compare the ratios of G2L3 expressing con-
trol cells and TSA-treated G2L3-expressing cells.
RESULTS
GAS2-like 3 Is Highly Conserved among Species and IsWidely
Expressed in Human Tissues—To identify potential actin and
MT-binding proteins, we performed a TBLASTN search for
genes containing both CH and GAR domains using GAS2 as a
template. As a proof of principle, we identified GAS2, G2L1,
G2L2, MACF1, bullous pemphigoid antigen 1, and picked eggs
(Pigs), but also an uncharacterized gene, G2L3 (GenBank/
EMBL/DDJB accession number AC_000144). It has an open
reading frame of 2229 base pairs, spanning eight exons and
encodes a putative protein of 694 amino acids (AAs) with a
calculated molecular mass of 75.2 kDa (Fig. 1A). The protein
sequence consists of a single N-terminal CH3 class, CH
domain comprising 122 AAs, with 24% AA identity to the
CH domain identified in calponin. C-terminal of the CH
domain is an 82-AA-long GAR domain, which abuts to a
stretch of 404 AAs that is predicted to have little secondary
structure. The domain organization of G2L3 is the same as
G2L1 and G2L2, therefore classifying it as a new member of
the GAS2 protein family.
G2L3 shares the highest AA identity to GAS2 (60%) and the
lowest identities with G2L1 and G2L2 at 30 and 36%, respec-
tively (Fig. 1, B and C). In terms of domain sequence conserva-
tion, the CH and GAR domains of G2L3 are compared with the
other members in Fig. 1C.
G2L3 homologues are present in all vertebrates; for example,
there is 65% identity between the conserved CH and GAR
domains belonging to the humanG2L3 and the zebrafish G2L3
(see supplemental Table S1). There is also evidence for the
existence of genes with the same domain architectures in Dro-
sophila melanogaster, where it has been named Pigs (accession
number NM_132103) (43). A similar gene is expressed in
Caenorhabditis elegans, where the CH domain has been dupli-
cated (accession number NM_069025). Taken together, we
have discovered a newmember of theGAS2 family by searching
for genes related to GAS2 that is highly conserved through evo-
lution, which implies it plays an important function.
We next sought to determine the expression of G2L3 in
human tissues and cell lines. Using cDNA libraries generated
fromdifferent human tissues and cell lines, we performed PCRs
to investigate the respective levels ofG2L3mRNAand used this
as an indication ofG2L3protein levels. G2L3mRNAwaswidely
expressed within the body and was most prominent in the pan-
creas, heart, liver, placenta, and lung. It was expressed at low
levels in the brain, skeletal muscle, and kidney (Fig. 2A).
Because tissues contain many different cell types, we investi-
gated whether G2L3 expression was confined to a particular
one. We discovered G2L3 in a wide variety of cell lines, includ-
ing HeLa, human foreskin fibroblasts, human embryonic kid-
ney 293 cells, and we found the murine homologue in NIH3T3
cells. Conversely, it was not expressed in HT1080 cells, which
are a highly transformed cell line (Fig. 2B). These data suggest
that G2L3 is abundantly expressed in many tissues and cell
lines. Notably, it is absent in HT1080 cells, which may indicate
a role in tumor suppression, as described for caveolin-1 (19).
The Calponin Homology Domain Mediates Localization to
Actin Stress Fibers and the C Terminus Recruits GAS2-like 3 to
Microtubules—To determine the subcellular localization of
G2L3 and to study the roles of its domains in this localization,
FIGURE 2.G2L3 is expressed ubiquitously in human tissues and cell lines.
A, PCRs were performed on cDNA panels generated from different tissues,
using primers specific for G2L3, which spanned exons 2 to 6. Primers
designed specifically to recognize -actin were used as loading controls.
B, PCRs were performed using cDNA libraries generated from different cell
lines. The human tissues, human cell lines (HeLa, HT1080, human foreskin
fibroblast (HFF), and HEK293) and mouse cell line (NIH3T3) are indicated
aboveeachpanel, the sizes ofDNAare indicatedon the left sideof thepanel in
bp, and theexpectedPCRproduct sizes are indicatedbyarrowheads. Note the
low expression of G2L3 in brain tissue and its absence in the HT1080 cell line.
The data are representative of three independent experiments.
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we expressed fluorophore-tagged versions of G2L3 and a series
of G2L3 mutants in NIH3T3 cells. We found that full-length
G2L3 localized to overlapping MTs and actin stress fibers in
70% of all tested cells and G2L3 localized only to MTs in the
remaining 25% of cells (Fig. 3A). The localization to actin was
mediated by theCHdomain, because expression of this domain
alone (referred to as G2L3-CH) decorated actin stress fibers in
all cells (Fig. 3,B andD). In contrast, a constructmissing theCH
domain (G2L3-CH) localized predominantly to MTs, sug-
gesting that the remaining sequence contained a MT-binding
site (Fig. 3, B and C). To our surprise, the localization to MTs
was mediated by the C terminus, because expression of this
domain (G2L3-C-term) localized exclusively to MTs (Fig. 3C).
Notably, the MTs appeared to be bundled in 82% of cells
expressing G2L3-C-term. To investigate whether the GAR
domain, a domain that has been frequently implicated in MT
FIGURE 3.G2L3 binds and localizes to bothmicrotubule and actin cytoskeletons. A, C, and D, G2L3 constructs were transiently expressed in NIH3T3 cells,
followed by fixation and staining using an antibody that recognizes-tubulin (DM1A) (41) and phalloidin to label actin. A, G2L3 localizes to both F-actin (white
arrowheads) and MT cytoskeletons (white arrows). B, G2L3 constructs that were expressed as fusion constructs to GFP or mCherry (mCh) in NIH3T3 cells.
C, G2L3-CH (CH), G2L3-GAR (GAR), andG2L3-C-term (C-term) all localize toMTs, andG2L3-GAR (GAR) localizes diffusely in the cytoplasm.D, G2L3-CH (CH)
and G2L3-C-term (C-term) localize to F-actin structures. E, actin binding assays were performed using recombinant versions of G2L3-CH (CH) and G2L3-C-
term (C-term), showing that the CH domain directly binds F-actin, whereas the C-term does not. F, MT-spin down assays were performed using G2L3-CH (CH)
andG2L3-GAR (GAR) as well as G2L3-C-term (C-term), showing that only G2L3-C-termdirectly interacts withMTs in vitro. The predicted sizes of the proteins are
indicated by arrowheads. Both immunofluorescence and binding assay data are representative of three independent experiments. Bars, 10 m.
G2L3, a NewMT- and Actin-binding Protein
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binding in other proteins (7), played a role in localizing G2L3
to either cytoskeleton, we generated mutants including and
excluding this domain (G2L3-GAR and G2L3-GAR, respec-
tively) (Fig. 3B).We found thatG2L3-GAR localized diffusely in
the cytoplasm in most cells and G2L3-GAR localized along
the MT lattice, implying that the GAR domain is not funda-
mental for G2L3 localization to MTs or actin (Fig. 3C). G2L3-
C-term, which lacks the C terminus but contains both the CH
and GAR domains, localized predominantly to the actin cyto-
skeleton but interestingly to different actin structures than
G2L3-CH. Specifically, G2L3-C-term localized to both lamel-
lipodia and filopodia (Fig. 3D).
Taken together, these data indicate that the CH domain con-
trols the localization of G2L3 to actin and the C terminus reg-
ulates its localization toMTs. The GAR domain is not essential
for localization to MTs, and the bundling of MTs by the C
terminus may imply that it has the ability to cross-link MTs.
GAS2-like 3 Interacts Directly with Microtubules and Fila-
mentous Actin—To determine whether the localization of the
individual domains of G2L3 is mediated by direct interactions
with the different cytoskeletal systems, we performed in vitro
cosedimentation assays using recombinant purified domains.
We found that purified G2L3-CH cosedimented with F-actin
after high speed centrifugation, indicating that there is a direct
interaction (Fig. 3E). Conversely, the majority of G2L3-C-term
remained in the supernatant. A small amount cosedimented
with F-actin; however, this is likely through a nonspecific inter-
action, as has been documented for positively charged peptides
(20). Given the exclusive localization of G2L3-C-term to MTs
in cells (Fig. 3C), we conclude that G2L3-C-termmediates MT
binding. As controls, the proteins were centrifuged in the
absence of polymerized actin, and both were found in the
supernatant, showing they fail to sediment alone. A similar
assay was performed with MTs, to reveal that G2L3-C-term
interacts directly with MTs (Fig. 3F). In contrast, neither
G2L3-CHnorG2L3-GARwere found in the pellet fractionwith
MTs, implying that neither interact directly withMTs (Fig. 3F).
Overall, these data are consistent with the immunofluores-
cence data, confirming that the CH domain binds to actin, and
the C terminus binds toMTs. These data suggest that the GAR
domain does not interact with MTs directly in vitro.
The Individual Domains of GAS2-like 3 Influence the Binding
Strength to Microtubules and F-actin—To study the influence
of the different domains of G2L3 on its binding strength to
F-actin or MTs, we performed FRAP experiments on cells
expressing different mutants (Fig. 4, A and B). In these experi-
ments, we determined the half-time (t1⁄2) of recovery of the dif-
ferent mutants, and used it as an indicator of protein mobility
(21, 22). In comparison with the subpopulation of G2L3 which
localized to actin, we observed a 2-fold increase in the t1⁄2 of
recovery of 28.5 s for G2L3-CH, indicating that the turnover of
theCHdomain is slower than full-lengthG2L3 (Fig. 4,A andC).
Conversely, G2L3-C-term showed a 6-fold decrease in t1⁄2 of
recovery of 2.5 s comparedwithG2L3, implying the turnover of
G2L3-C-term is faster and has a weaker interactionwith actin
than G2L3. These data indicate that the removal of the GAR
domain and the C terminus amplifies the binding strength of
the CHdomain for actin. Accordingly, the presence of the GAR
FIGURE 4. The individual domains of G2L3 influence the binding strength to microtubules and actin. To assess the turnover of indicated proteins in
NIH3T3 cells, circular areas of 1.5-mdiameter were bleached, and recoverywasmeasured. A, FRAP experiments performed on the actin localizing constructs.
Note the slower fluorescence recovery of bleached areas in G2L3-CH (CH)-expressing cells and much faster recovery in G2L3-C-term expressing cells
comparedwith areas inG2L3-expressing cells. B, FRAP experiments performedonMT localizing constructs. Note the similar fluorescence recovery of bleached
areas in cells expressing G2L3 and G2L3-CH. Conversely, the fluorescence recovers faster in the bleached areas in G2L3-GAR and G2L3-C-term-expressing
cells. Either the prebleach (PRE) or the time in seconds is indicated in the bottom right-hand corner of each image, and the encircled areas indicate the bleach
regions.C, the t1⁄2 values of recovery of the actin binding constructs are labeled ingray, and theMT-binding constructs are inblack. Note that the t1⁄2 of recovery
of G2L3-CH is almost double that of G2L3, and the t1⁄2 of recovery of G2L3-C-term is much faster than G2L3. In accordance with B, the t1⁄2 of recovery of
G2L3-CH is similar toG2L3,whereasG2L3-GAR andG2L3-C-termhavemuch faster t1⁄2 values of recovery. The data represent the results frommore than n
20 bleach regions from n 10 cells and are representative of three independent experiments. Bars, 5 m.
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domain alone is sufficient to destabilize the interaction of the
CH domain with actin. We subsequently analyzed the mobility
of the various constructs that localized to MTs (Fig. 4B). We
discovered that full-length G2L3 and the construct lacking the
CH domain (G2L3-CH) had the slowest turnovers, with t1⁄2
values of recovery of 14.9 and 15.3 s, respectively. Suggesting
that the CH domain does not affect the interaction of G2L3
with MTs. In contrast, the t1⁄2 of recovery of G2L3-C-term was
reduced almost 4-fold (3.9 s), and the t1⁄2 of recovery of G2L3-
GARwasmore than halved (6 s) (Fig. 4C). These data indicate
that the simultaneous removal of both the CH and GAR
domains destabilizes the interaction of the C terminus with
MTs. In summary, the results suggest a critical role for theGAR
domain in modulating the binding to the different cytoskeletal
systems, strengthening the interaction with MTs, but weaken-
ing the interaction with F-actin.
GAS2-like 3 Localization Is Dependent on Both Microtubule
and Actin Cytoskeletons—The localization of G2L3 was vari-
able in cells. In 70% of cells, G2L3 localized to both MTs and
F-actin, in 25%of cells it localized exclusively toMTs, and in the
remaining 5% it localized diffusely. The cause of this variability
is unclear; however, the presence of both MT- and actin-bind-
ing sites on G2L3 may provide insights and raises the question
whether the interaction of G2L3 with one of the cytoskeletons
influences the binding to the other. To elucidate this, we dis-
rupted the actin cytoskeleton using cytochalasin D, which
resulted in G2L3 localizing more to MTs (83% compared with
25% in untreated control cells) (Fig. 5). These data suggest that
F-actin is not required for G2L3 localization to MTs. After
treatment of cells with nocodazole to ablate MTs, G2L3 local-
ized diffusely in many cells (48% compared with 5% in control
cells). In a small percentage of cells treated with nocodazole,
G2L3 localized to the actin cytoskeleton (7%). Notably, G2L3
localization was enhanced to nocodazole-resistant MTs, in a
subset of cells. These data imply thatMTs aidG2L3 localization
to F-actin; however, they are not fundamental for it. In sum-
mary, these data suggest that G2L3 is able to localize indepen-
dently to both F-actin andMTs; however, the presence of MTs
aids G2L3 localization to F-actin.
Post-translational Acetylation of Tubulin Enhances GAS2-
like 3 Localization to Microtubules—The enhancement of
localization of G2L3 to remnant MTs after nocodazole treat-
ment suggests that G2L3 preferentially binds to stable MTs.
One way MTs can be stabilized against nocodazole is through
post-translational modifications of tubulin, such as acetylation
(23). To examine this possibility, we treated G2L3-GFP-ex-
pressing cells with the histone deacetylase 6 inhibitor, TSA,
which dramatically increases the amount of acetylated -tubu-
lin (Fig. 6A). This increase in tubulin acetylation led to a small,
although significant and reproducible, 9% increase in G2L3
recruitment to MTs in comparison with Me2SO-treated con-
trol cells (Fig. 6, B and D). This increase was not due to the
possible stabilization of MTs by the inhibitor per se, because
MTs stabilized by taxol were not found to increase G2L3 local-
ization (data not shown).
In summary, these data suggest that G2L3 localization may
be regulated by molecular mechanisms that lead to MT acety-
lation. It is currently unclear as to how tubulin acetylation
recruits G2L3 to MTs and adds to the list of proteins that are
regulated by post-translational modifications of tubulin.
DISCUSSION
We have characterized a new member of the GAS2 family,
G2L3, that is highly conserved and expressed in many tissues.
G2L3 binds to both F-actin and MTs via its single CH domain
and unstructured C terminus, respectively. Moreover, we have
shown that the GAR domain can modulate the interaction
strength of G2L3 with both actin and MTs and that tubulin
acetylation enhances G2L3 localization to MTs.
A Single Type 3-Calponin Homology DomainMediates Actin
Binding—Actin-binding of many prominent proteins such as
MACF1 and -actinin is mediated very efficiently by tandem
type 1 (CH1) and type 2 (CH2) CHdomain repeats (24, 25). The
importance of the tandem repeat has been highlighted, because
the removal of the CH1 domain in MACF1 ablates its actin
binding ability, despite the presence of the remaining CH2
domain (26).
In contrast to the tandem CH1 and CH2 domain repeats,
single CH3 domains such as those found in calponin and MT
end-binding proteins are considered to be inefficient actin-
binding domains (25, 27). It is hypothesized that CH3 domains
serve to locate canonical actin-binding domains, for example
FIGURE 5.Neither the integrity of actin nor that of microtubules is a pre-
requisite for G2L3 localization to microtubules or actin cytoskeletons,
respectively.A, NIH3T3 cells expressingG2L3were treatedwith either 10M
nocodazole (NOC) or 2 M cytochalasin D (CYTO D) for 30 min to determine
their effects on G2L3 localization. Note that G2L3 can localize to stable MTs
(top row, black arrow) and actin filaments (top row, black arrowheads) after
NOC treatment, whereas G2L3 predominantly localizes to MTs (bottom row,
black arrow) after treatment of cells with cytochalasin D. B, the subcellular
localization of G2L3 in cells was quantified after treatment with nocoda-
zole or cytochalasin D. Note that G2L3 localizes diffusely in a greater pro-
portion of cells after NOC treatment, whereas G2L3 localizes to MTs in
more cells after cytochalasin D (Cyto D) treatment. More than 50 cells were
counted for each treatment and are representative of three independent
experiments. Bars, 10 m.
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the CH3 domain on calponin is thought to interact with the
CH1 domain on-actinin and bring it in proximity to actin (28,
29). Despite this evidence, we found that the single CH3
domain in G2L3 does indeed function as an actin-binding
domain, an observation that is supported by the other GAS2
family members (2). Interestingly, full-length G2L3 only local-
izes to actin stress fibers in a subset of cells, implying that the
mechanism of CH3 domain binding to actin, in the context of
the full-length protein, is tightly regulated. In support of this,
our FRAP experiments show lower binding strength to actin
when theCHdomain is coupledwith theGARdomain andmay
suggest that the latter domain contains a motif that can modu-
late actin binding. This is further substantiated by F-actin sed-
imentation assays of G2L2, in which actin was less able to sed-
iment G2L2 than the truncated splice mutant encoding the
single CH domain (G2L2) (2).
TheCTerminus Is Essential for EfficientMicrotubule Binding—
We discovered that the C terminus in G2L3 is fundamental for
binding to theMT cytoskeleton and is able to bundleMTs. The
highly positively charged C terminus in G2L3 may electrostat-
ically interact with negatively chargedMTs, bringing individual
MTs together to form MT bundles.
Given the high degree of similarity between theGARdomain
in G2L3 and the publishedMT-binding GAR domains in GAS2
(63% identity) and MACF1 (38%), we predicted that the G2L3-
GAR domain would interact with MTs. Conversely to our
hypothesis, we found that the GAR domain in G2L3 localizes
very weakly to MTs in cells and is unable to bind to them in
vitro. Our observations are similar to those described for G2L1
and G2L2 (2). This raises an important question as to how the
other GAR domains mediate this interaction. Initial sequence
analyses revealed that the otherGARdomains have overall pos-
itive charges, ranging from2 to6, whereas the G2L3-GAR
has a net charge of zero. Because MTs have an overall negative
charge, one likely possibility is that the GAR domains of other
proteins interact electrostatically, as has been shown for cati-
onic peptides (30). Further examination of the other GAR
domains, based upon the NMR structure of the GAR domain
fromGAS2, exposed a weakness in construct design. For exam-
ple, the GAR domain in GAS2 appears to be missing a final
methionine residue, which is predicted to form part of the last
-helix (7). Also, the GAR domain used in a recent study on the
Drosophila spectraplakin, Shot (31), lacks the first four resi-
dues, which form part of the initial -helix. This study showed
that the GAR domain localized to MTs very strongly. Both of
these published GAR domains are likely to fold incorrectly and
may act similarly to the positively charged and unfolded C ter-
minus of G2L3. The comparisons are based upon the NMR
structure of the GAR domain from GAS2. Despite these obser-
vations, it appears that the G2L3-GAR domain contributes
slightly toMT binding strength because our FRAP data suggest
that the presence of the GAR domain increases the binding
strength ofG2L3 toMTs.We speculate that theGARdomain in
G2L3, and indeed in other proteins, interacts with MT-associ-
ated proteins, which modulate binding to the microtubular
network.
Acetylation Contributes to GAS2-like 3 Recruitment to
Microtubules—It has been reported previously that detyrosina-
tion and acetylation of -tubulin are hallmarks of MT stabili-
zation (32, 33).We discovered that G2L3 localization toMTs is
FIGURE 6.Post-translational acetylationof tubulin enhancesG2L3 localization tomicrotubules.A, NIH3T3 cellswere treatedwith TSA andwere fixed and
costained using antibodies directed against -tubulin (DM1A) and acetylated -tubulin (6–11B-1) (42). Note the low amount of acetylated tubulin in the total
MT population in untreated cells (white arrows), when comparedwith TSA-treated cells (white arrowheads). B, NIH3T3 cells expressing G2L3were treatedwith
Me2SO (TSA) or TSA (TSA) and were fixed and stained using the DM1A antibody. Note the enhancement of G2L3 to MTs following TSA treatment (white
arrowheads) compared with Me2SO-treated control cells (white arrows). C, G2L3 and MT images were passed through a FFT two-dimensional bandpass filter
and background subtracted. The resulting image was thresholded to MTs, and the cell outline was drawn. Subsequently, the area fraction for G2L3 positive
pixels and MTs were recorded, and the ratio between G2L3 and MTs was calculated. D, the enhancement of G2L3 to MTs was quantified as in C, to show that
G2L3 localizationwasenhanced toMTsafter treatmentof TSA.More than50cellswere counted for eachconditionandare representativeof three independent
experiments. Error bars, S.E. (p 0.01, Student’s t test). Bars, 10 m.
G2L3, a NewMT- and Actin-binding Protein
24994 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 286•NUMBER 28•JULY 15, 2011
 at K
IN
G
'S CO
LLEG
E LO
N
D
O
N
 on O
ctober 6, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
enhanced to acetylated MTs, which is similar to other MT-in-
teracting proteins such as themotor protein, kinesin-1 (34, 35).
Although the function of this regulation is unclear, parallels can
be drawn to the function of tubulin detyrosination. Recently it
has been shown that detyrosination of -tubulin effects the
recruitment of proteins that contain a cytoskeleton-associated
protein glycine-rich domain (36). Proteins containing these
domains include the MT plus end-binding proteins, CLIP-170,
and p150glued, which can regulateMTdynamics and targeting.
Thus, it is possible that localized tubulin acetylation can drive
recruitment of G2L3 to specific loci within the cell, where it
then exerts its function.
The Similarity to Spectraplakins—Members of the GAS2
family and the spectraplakins have a similar domain organiza-
tion, they bind equally to MTs and actin, they both localize
similarly in cells, and they exhibit similar behavior in response
to cytoskeleton-disrupting drugs (37). These findings strongly
suggest they may have similar functions. ACF7 regulates MT
growth as well as the dynamics of focal adhesions associated
with F-actin (4). Targeting of focal adhesions by MTs is essen-
tial for focal adhesion turnover (38), and disrupting MTs leads
to inhibition of cell migration (39).MTs grow along F-actin and
can thus be guided to adhesion sites (40).5 In the absence of
ACF7, MT growth is unlinked from F-actin in epidermal cells,
leading to a diminished turnover rate of focal adhesions and
proteins therein (4). Given the potential exciting roles the
GAS2 family may play in cell motility, future experiments will
be necessary to clarify whether G2L3 or other members of the
GAS2 family exert a similar function.With the potential role of
stable MTs in migration (33), one possible avenue of investiga-
tion will be into the role of tubulin acetylation, and the proteins
that mediate this, because they may govern G2L3 function.
Acknowledgments—We are grateful to Dr. Janet Askari for critical
reading of themanuscript.We thankKarolina Zielinska (Cambridge)
for technical assistance. We thank Peter March and the members of
the Faculty of Life Sciences Bioimaging core facility for the help with
various microscopes.
REFERENCES
1. Li, R., and Gundersen, G. G. (2008) Nat. Rev. Mol. Cell. Biol. 9, 860–873
2. Goriounov, D., Leung, C. L., and Liem, R. K. (2003) J. Cell Sci. 116,
1045–1058
3. Kodama, A., Karakesisoglou, I., Wong, E., Vaezi, A., and Fuchs, E. (2003)
Cell 115, 343–354
4. Wu, X., Kodama, A., and Fuchs, E. (2008) Cell 135, 137–148
5. Jefferson, J. J., Leung, C. L., and Liem, R. K. (2004)Nat. Rev.Mol. Cell. Biol.
5, 542–553
6. Sonnenberg, A., and Liem, R. K. (2007) Exp. Cell Res. 313, 2189–2203
7. Sun, D., Leung, C. L., and Liem, R. K. (2001) J. Cell Sci. 114, 161–172
8. Schneider, C., King, R. M., and Philipson, L. (1988) Cell 54, 787–793
9. Brancolini, C., Bottega, S., and Schneider, C. (1992) J. Cell Biol. 117,
1251–1261
10. Brancolini, C., and Schneider, C. (1994) J. Cell Biol. 124, 743–756
11. Lee, K. K., Tang, M. K., Yew, D. T., Chow, P. H., Yee, S. P., Schneider, C.,
and Brancolini, C. (1999) Dev. Biol. 207, 14–25
12. Brancolini, C., Benedetti, M., and Schneider, C. (1995) EMBO J. 14,
5179–5190
13. Zucman-Rossi, J., Legoix, P., and Thomas, G. (1996) Genomics 38,
247–254
14. Kammerer, R. A., Schulthess, T., Landwehr, R., Lustig, A., Fischer, D., and
Engel, J. (1998) J. Biol. Chem. 273, 10602–10608
15. Kammerer, R. A., Antonsson, P., Schulthess, T., Fauser, C., and Engel, J.
(1995) J. Mol. Biol. 250, 64–73
16. Studier, F. W. (2005) Protein Expr. Purif. 41, 207–234
17. Edelhoch, H. (1967) Biochemistry 6, 1948–1954
18. Clamp, M., Cuff, J., Searle, S. M., and Barton, G. J. (2004) Bioinformatics
20, 426–427
19. Wiechen, K., Sers, C., Agoulnik, A., Arlt, K., Dietel, M., Schlag, P. M., and
Schneider, U. (2001) Am. J. Pathol. 158, 833–839
20. Wohnsland, F., Schmitz, A. A., Steinmetz, M. O., Aebi, U., and Verge´res,
G. (2000) J. Biol. Chem. 275, 20873–20879
21. Carisey, A., Stroud,M., Tsang, R., and Ballestrem, C. (2011)MethodsMol.
Biol., in press
22. Humphries, J. D., Wang, P., Streuli, C., Geiger, B., Humphries, M. J., and
Ballestrem, C. (2007) J. Cell Biol. 179, 1043–1057
23. Gundersen,G.G., Kim, I., andChapin, C. J. (1994) J. Cell Sci.107, 645–659
24. Ro¨per, K., Gregory, S. L., and Brown, N. H. (2002) J. Cell Sci. 115,
4215–4225
25. Gimona, M., Djinovic-Carugo, K., Kranewitter, W. J., and Winder, S. J.
(2002) FEBS Lett. 513, 98–106
26. Lee, S., and Kolodziej, P. A. (2002) Development 129, 1195–1204
27. Gimona, M., and Mital, R. (1998) J. Cell Sci. 111, 1813–1821
28. Leinweber, B. D., Leavis, P. C., Grabarek, Z., Wang, C. L., and Morgan,
K. G. (1999) Biochem. J. 344, 117–123
29. Galkin, V. E., Orlova, A., Fattoum, A., Walsh, M. P., and Egelman, E. H.
(2006) J. Mol. Biol. 359, 478–485
30. Wolff, J. (1998) Biochemistry 37, 10722–10729
31. Applewhite, D. A., Grode, K. D., Keller, D., Zadeh, A., Slep, K. C., and
Rogers, S. L. (2010)Mol. Biol. Cell 21, 1714–1724
32. Webster, D. R., and Borisy, G. G. (1989) J. Cell Sci. 92, 57–65
33. Gundersen,G.G., andBulinski, J. C. (1988)Proc.Natl. Acad. Sci. U.S.A.85,
5946–5950
34. Reed, N. A., Cai, D., Blasius, T. L., Jih, G. T., Meyhofer, E., Gaertig, J., and
Verhey, K. J. (2006) Curr. Biol. 16, 2166–2172
35. Dompierre, J. P., Godin, J. D., Charrin, B. C., Cordelie`res, F. P., King, S. J.,
Humbert, S., and Saudou, F. (2007) J. Neurosci. 27, 3571–3583
36. Mishima, M., Maesaki, R., Kasa, M., Watanabe, T., Fukata, M., Kaibuchi,
K., and Hakoshima, T. (2007) Proc. Natl. Acad. Sci. U.S.A. 104,
10346–10351
37. Karakesisoglou, I., Yang, Y., and Fuchs, E. (2000) J. Cell Biol. 149, 195–208
38. Kaverina, I., Krylyshkina, O., and Small, J. V. (1999) J. Cell Biol. 146,
1033–1044
39. Ballestrem, C., Wehrle-Haller, B., Hinz, B., and Imhof, B. A. (2000) Mol.
Biol. Cell 11, 2999–3012
40. Rodriguez, O. C., Schaefer, A. W., Mandato, C. A., Forscher, P., Bement,
W. M., and Waterman-Storer, C. M. (2003) Nat. Cell Biol. 5, 599–609
41. Blose, S. H., Meltzer, D. I., and Feramisco, J. R. (1984) J. Cell Biol. 98,
847–858
42. LeDizet, M., and Piperno, G. (1991)Methods Enzymol. 196, 264–274
43. Pines, M. K., Housden, B. E., Bernard, F., Bray, S. J., and Roper, K. (2010)
Development 137, 913–9225 M. J. Stroud, R. A. Kammerer, and C. Ballestrem, unpublished observations.
G2L3, a NewMT- and Actin-binding Protein
JULY 15, 2011•VOLUME 286•NUMBER 28 JOURNAL OF BIOLOGICAL CHEMISTRY 24995
 at K
IN
G
'S CO
LLEG
E LO
N
D
O
N
 on O
ctober 6, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Matthew J. Stroud, Richard A. Kammerer and Christoph Ballestrem
Protein Related to Spectraplakins
Characterization of G2L3 (GAS2-like 3), a New Microtubule- and Actin-binding
doi: 10.1074/jbc.M111.242263 originally published online May 11, 2011
2011, 286:24987-24995.J. Biol. Chem. 
  
 10.1074/jbc.M111.242263Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
Supplemental material:
  
 http://www.jbc.org/content/suppl/2011/05/11/M111.242263.DC1.html
  
 http://www.jbc.org/content/286/28/24987.full.html#ref-list-1
This article cites 42 references, 23 of which can be accessed free at
 at K
IN
G
'S CO
LLEG
E LO
N
D
O
N
 on O
ctober 6, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
